Clinical Trials Logo

Clinical Trial Summary

The prevalence of myopia and severe myopia are increasing and will affect 50% and 10% of the population respectively. Severe myopia exposes an increased risk of glaucoma, cataract, retinal detachment and myopic maculopathy, a source of visual impairment. To date, no European cohort study has been conducted to estimate the rate of these complications and to study the predictive parameters.


Clinical Trial Description

This study allows to describe the evolution of different ophthalmological parameters of a population of strong myopes during their follow-up for 10 years using multimodal imaging techniques of the retina. Prospective, longitudinal, multicentric, non-randomized cohort study with constitution of a biological collection. This study will include major and minor patients with high myopia ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05849974
Study type Interventional
Source Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Contact Nabil BROUK
Phone +331 40 02 11 26
Email nbrouk@15-20.fr
Status Not yet recruiting
Phase N/A
Start date June 2023
Completion date May 2038